Viewing Study NCT00191503


Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2025-12-25 @ 5:24 PM
Study NCT ID: NCT00191503
Status: COMPLETED
Last Update Posted: 2007-01-26
First Post: 2005-09-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module